Literature DB >> 11110711

Similar pattern of thymic-dependent T-cell reconstitution in infants with severe combined immunodeficiency after human leukocyte antigen (HLA)-identical and HLA-nonidentical stem cell transplantation.

S M Müller1, T Kohn, A S Schulz, K M Debatin, W Friedrich.   

Abstract

Donor T cells after stem cell transplantation reconstitute by 2 different pathways: by expansion from grafted, mature T cells and by intrathymic maturation from progenitor cells. This study characterized thymic-dependent reconstitution of CD4(+) T cells following different transplant modalities in patients with severe combined immunodeficiency (SCID). Three groups of patients were studied: one group after transplantation from human leukocyte antigen (HLA)-identical siblings with unmanipulated grafts without conditioning, a second group after transplantation from HLA-nonidentical parents with T-cell-depleted grafts without preconditioning, and a third group with prior conditioning. Reconstitution of the T-cell compartment was monitored by determining the expression of CD45 isoforms by developing CD4(+) cells in the peripheral blood and in discriminating expanded (CD45RO(+)) and newly generated (CD45RA(+)) T cells. Concomitantly, changes in the size of the thymus were evaluated sequentially by ultrasonography. Reconstitution of CD4(+)CD45RA(+) cells was delayed in all patients for several months, including patients after HLA-identical transplantation, and was always paralleled by normalization of the size of the thymus. No engraftment of donor progenitor cells was observed, as studied in one patient transplanted without conditioning. CD4(+)CD45RO(+) cells were detected early after transplantation only in patients given unmanipulated grafts. The study showed that thymic-dependent T-cell maturation in these patients with SCID runs an autonomous course, independent of graft manipulation, of major HLA disparities, and of whether conditioning is used or not. In addition, thymic maturation may not require engraftment of donor-derived CD34(+) cells in the marrow. (Blood. 2000;96:4344-4349)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11110711

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

Review 1.  Survival of the fittest: in vivo selection and stem cell gene therapy.

Authors:  Tobias Neff; Brian C Beard; Hans-Peter Kiem
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

2.  Hematopoietic stem cells: the paradigmatic tissue-specific stem cell.

Authors:  David Bryder; Derrick J Rossi; Irving L Weissman
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 3.  Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.

Authors:  Jennifer Heimall; Jennifer Puck; Rebecca Buckley; Thomas A Fleisher; Andrew R Gennery; Benedicte Neven; Mary Slatter; Elie Haddad; Luigi D Notarangelo; K Scott Baker; Andrew C Dietz; Christine Duncan; Michael A Pulsipher; Mort J Cowan
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-06       Impact factor: 5.742

Review 4.  Immunological aspects of 22q11.2 deletion syndrome.

Authors:  A R Gennery
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

Review 5.  Long term outcomes of severe combined immunodeficiency: therapy implications.

Authors:  Jennifer Heimall; Morton J Cowan
Journal:  Expert Rev Clin Immunol       Date:  2017-09-23       Impact factor: 4.473

6.  Clonotypic analysis of T cell reconstitution after haematopoietic stem cell transplantation (HSCT) in patients with severe combined immunodeficiency.

Authors:  H Okamoto; C Arii; F Shibata; T Toma; T Wada; M Inoue; Y Tone; Y Kasahara; S Koizumi; Y Kamachi; Y Ishida; J Inagaki; M Kato; T Morio; A Yachie
Journal:  Clin Exp Immunol       Date:  2007-03-21       Impact factor: 4.330

7.  Purified hematopoietic stem cell transplantation: the next generation of blood and immune replacement.

Authors:  Agnieszka Czechowicz; Irving L Weissman
Journal:  Hematol Oncol Clin North Am       Date:  2011-02       Impact factor: 3.722

8.  Niche recycling through division-independent egress of hematopoietic stem cells.

Authors:  Deepta Bhattacharya; Agnieszka Czechowicz; A G Lisa Ooi; Derrick J Rossi; David Bryder; Irving L Weissman
Journal:  J Exp Med       Date:  2009-11-02       Impact factor: 14.307

9.  Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches.

Authors:  Agnieszka Czechowicz; Daniel Kraft; Irving L Weissman; Deepta Bhattacharya
Journal:  Science       Date:  2007-11-23       Impact factor: 47.728

10.  Long-term follow-up in patients with severe combined immunodeficiency treated by bone marrow transplantation.

Authors:  Wilhelm Friedrich; Manfred Hönig; Susanna M Müller
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.